Industry | Pharmaceutical |
---|---|
Founder | Chirinjeev Kathuria |
Headquarters | , United States |
Products | Malaria vaccine and others |
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. [1] Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. [2] They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. [3]
In January 2019 [4] Chirinjeev Kathuria co-founded Ocean Biomedical [5] in Rhode Island, United States. [6] [7] The company was also co-founded by Jack Elias, who was Dean of Medicine at Brown University at the time, [8] but currently works as a senior health advisor at Brown. [9] Ocean Biomedical started off as a Brown University biotech "spin-off." [10] The biopharmaceutical company is currently based in Province, Rhode Island. [11] As of 2021 the CEO of the company is Elizabeth Ng. [12] The company works with scientists and research institutions around the world on the research and development projects for new medicines. [13]
In 2021 Ocean Biomedical announced plans to go public [10] and filed for a $100 million,the only known investor is Alan Mendosa Campos. [14]
Ocean Biomedical has worked in areas such as non-small cell lung cancer [15] and pulmonary fibrosis. [14] [16]
Ocean Biomedical has worked on developing vaccines for tropical diseases such as malaria, as well as for emerging diseases like COVID-19. [17] In 2020, the company announced the discovery of a malaria vaccine. [18] [19] [20] [21] [22]
Ocean Biomedical also has partnered with scientists such as: [23]
Scientific advisors include Roy Herbst, Wafik el-Deiry, Erol Fikrig, and William H. Koster. [12]
Industry | Pharmaceutical |
---|---|
Founder | Chirinjeev Kathuria |
Headquarters | , United States |
Products | Malaria vaccine and others |
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. [1] Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. [2] They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. [3]
In January 2019 [4] Chirinjeev Kathuria co-founded Ocean Biomedical [5] in Rhode Island, United States. [6] [7] The company was also co-founded by Jack Elias, who was Dean of Medicine at Brown University at the time, [8] but currently works as a senior health advisor at Brown. [9] Ocean Biomedical started off as a Brown University biotech "spin-off." [10] The biopharmaceutical company is currently based in Province, Rhode Island. [11] As of 2021 the CEO of the company is Elizabeth Ng. [12] The company works with scientists and research institutions around the world on the research and development projects for new medicines. [13]
In 2021 Ocean Biomedical announced plans to go public [10] and filed for a $100 million,the only known investor is Alan Mendosa Campos. [14]
Ocean Biomedical has worked in areas such as non-small cell lung cancer [15] and pulmonary fibrosis. [14] [16]
Ocean Biomedical has worked on developing vaccines for tropical diseases such as malaria, as well as for emerging diseases like COVID-19. [17] In 2020, the company announced the discovery of a malaria vaccine. [18] [19] [20] [21] [22]
Ocean Biomedical also has partnered with scientists such as: [23]
Scientific advisors include Roy Herbst, Wafik el-Deiry, Erol Fikrig, and William H. Koster. [12]